A case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma

被引:0
作者
Akiko Ishigami
Shogo Inaka
Yuko Ishida
Mizuho Nosaka
Yumi Kuninaka
Hiroki Yamamoto
Emi Shimada
Akihiko Kimura
Fukumi Furukawa
Toshikazu Kondo
机构
[1] Wakayama Medical University,Department of Forensic Medicine
来源
Forensic Science, Medicine and Pathology | 2024年 / 20卷
关键词
Percutaneous radiofrequency ablation; Hemoperitoneum; Hepatocellular carcinoma; Forensic autopsy; Complication;
D O I
暂无
中图分类号
学科分类号
摘要
We report a case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma. A 60-year-old female was hospitalized for the treatment of thrombasthenia and cirrhosis caused by chronic Hepatitis C, and computed tomography revealed hepatocellular carcinoma, which was treated by percutaneous radiofrequency ablation. After the ablation, hemoperitoneum was suspected because of the low hemoglobin level with abdominal pain. Approximately 6 h after the ablation treatment, the patient suddenly fell into a shock state and died. In this case, medical treatment-related death including malpractice was suspected, and forensic autopsy was performed. The abdominal cavity contained 910 mL of dark red fluid blood and 210 g of soft hemocoagula. Moreover, several puncture marks were observed on the liver surface and diaphragm, and there was no clear damage to the main arteries and veins. Considering the macroscopic and microscopic findings, the cause of death was assumed as hemorrhagic shock due to the hemoperitoneum caused by the damage to the liver by radiofrequency ablation. It is important to consider all the indications and adverse effects of radiofrequency ablation.
引用
收藏
页码:189 / 193
页数:4
相关论文
共 109 条
  • [1] Sherman M(2010)Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis Semin Liver Dis 30 3-16
  • [2] Bertot LC(2011)Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review Eur Radiol 21 2584-2596
  • [3] Sato M(2012)Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients J Gastroenterol 47 1125-1133
  • [4] Tateishi R(2007)Japanese experience in ablation therapies for hepatocellular carcinoma Hepatol Res 37 S223-S229
  • [5] Yoshida H(2013)Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques Clin Radiol 68 608-615
  • [6] Koike K(2007)Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver Anticancer Res 27 2911-2916
  • [7] Sato M(2010)Quality improvement guidelines for radiofrequency ablation of liver tumours Cardiovasc Intervent Radiol 33 11-17
  • [8] Tateishi R(2000)Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions Radiology 214 761-768
  • [9] Yasunaga H(2008)The safety of radiofrequency thermal ablation in the treatment of liver malignancies Eur J Surg Oncol 34 668-672
  • [10] Horiguchi H(2012)Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: an analysis of 16 346 treated nodules in 13 283 patients Hepatol Res 42 1058-1064